0000899243-16-012449.txt : 20160201
0000899243-16-012449.hdr.sgml : 20160201
20160201170049
ACCESSION NUMBER: 0000899243-16-012449
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160128
FILED AS OF DATE: 20160201
DATE AS OF CHANGE: 20160201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENXBIO Inc.
CENTRAL INDEX KEY: 0001590877
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 240-552-8181
MAIL ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: REGENXBIO, Inc.
DATE OF NAME CHANGE: 20150116
FORMER COMPANY:
FORMER CONFORMED NAME: ReGenX Biosciences, LLC
DATE OF NAME CHANGE: 20131101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vasista Vittal
CENTRAL INDEX KEY: 0001652827
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37553
FILM NUMBER: 161378062
MAIL ADDRESS:
STREET 1: 9712 MEDICAL CENTER DRIVE
STREET 2: SUITE 100
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-01-28
0
0001590877
REGENXBIO Inc.
RGNX
0001652827
Vasista Vittal
C/O REGENXBIO INC.
9712 MEDICAL CENTER DRIVE, SUITE 100
ROCKVILLE
MD
20850
0
1
0
0
See Remarks
Stock Option (Right to Buy)
13.09
2016-01-28
4
A
0
75000
0.00
A
2026-01-27
Common Stock
75000
75000
D
25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following 1/28/2017 while the optionee provides continuous service to the Issuer.
Senior Vice President of Corporate Development
/s/ Vittal K. Vasista
2016-01-29